Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Risks and Burdens of Incident Diabetes in Long COVID
- Urinary Albumin/Creatinine Ratio Tertiles Predict Risk of Diabetic Retinopathy Progression
- Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of HF Hospitalization
- Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation
- Effectiveness and Safety of Anticoagulation Therapy in Patients With Frailty and AF
- Characteristics and Outcomes of Type 2 MI
- Long-Term Cardiovascular Outcomes of COVID-19
- Primary Prevention of CV and HF Events With SGLT2i, GLP-1RA, and Their Combination in T2D
- Protection Against SARS-CoV-2 After Covid-19 Vaccination and Previous Infection
- SARS-CoV-2 Reinfection in Previously Infected Persons With and Without Subsequent Receipt of a Single Dose of the BNT162b2 Vaccine